-
Something wrong with this record ?
Mutational biosynthesis of neomycin analogs by a mutant of neomycin-producing Streptomyces fradiae
G. Shi, X. Zhang, L. Wu, J. Xie, K. Tao, T. Hou,
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22083789
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents biosynthesis chemistry MeSH
- Bacterial Proteins genetics metabolism MeSH
- Molecular Structure MeSH
- Mutation MeSH
- Neomycin analogs & derivatives biosynthesis MeSH
- Streptomyces enzymology genetics metabolism MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Neomycin, produced by Streptomyces fradiae, has been widely used for the treatment of bacterial infections in clinical and agricultural applications. In this study, a neomycin nonproducing mutant of S. fradiae was obtained by gene disruption technique for mutational biosynthesis. A crucial gene neoC (neo7) which encodes 2-deoxystreptamine (2-DOS) synthases was disrupted. The mutant could resume producing neomycin in the presence of 2-DOS. Salen derivatives of 2-DOS were synthesized and individually added to cultures of the mutant. Antibacterial activity of the mutasynthesis products against Staphylococcus aureus and four plant pathogenic bacteria (Pseudomonas solanacarum, Erwinia carotovora, Xanthomonas oryzae, and Xanthomonas campestris) was detected quantitatively by Oxford cup method. It is suggested that all 2-DOS derivatives were incorporated by the mutant into new active neomycin analogs except for 2-DOS derivative 2d ((1R,2r,3S,4R,6S)-4,6-bis((E)-3,5-di-tert-butyl-2-hydroxybenzylideneamino)cyclohexane-1,2,3-triol). Neomycin analogs produced by feeding 2-DOS derivative 2a ((1R,2r,3S,4R,6S)-4,6-bis((E)-2 hydroxybenzylideneamino)cyclohexane-1,2,3-triol) to cultures of the mutant displayed a similar antibacterial activity with neomycin produced by wild strain.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12035190
- 003
- CZ-PrNML
- 005
- 20121213145221.0
- 007
- ta
- 008
- 121023s2011 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $2 doi $a 10.1007/s12223-011-0082-5
- 035 __
- $a (PubMed)22083789
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Shi, Guanying $u Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, Sichuan University, Chengdu, Sichuan 610064, People's Republic of China.
- 245 10
- $a Mutational biosynthesis of neomycin analogs by a mutant of neomycin-producing Streptomyces fradiae / $c G. Shi, X. Zhang, L. Wu, J. Xie, K. Tao, T. Hou,
- 520 9_
- $a Neomycin, produced by Streptomyces fradiae, has been widely used for the treatment of bacterial infections in clinical and agricultural applications. In this study, a neomycin nonproducing mutant of S. fradiae was obtained by gene disruption technique for mutational biosynthesis. A crucial gene neoC (neo7) which encodes 2-deoxystreptamine (2-DOS) synthases was disrupted. The mutant could resume producing neomycin in the presence of 2-DOS. Salen derivatives of 2-DOS were synthesized and individually added to cultures of the mutant. Antibacterial activity of the mutasynthesis products against Staphylococcus aureus and four plant pathogenic bacteria (Pseudomonas solanacarum, Erwinia carotovora, Xanthomonas oryzae, and Xanthomonas campestris) was detected quantitatively by Oxford cup method. It is suggested that all 2-DOS derivatives were incorporated by the mutant into new active neomycin analogs except for 2-DOS derivative 2d ((1R,2r,3S,4R,6S)-4,6-bis((E)-3,5-di-tert-butyl-2-hydroxybenzylideneamino)cyclohexane-1,2,3-triol). Neomycin analogs produced by feeding 2-DOS derivative 2a ((1R,2r,3S,4R,6S)-4,6-bis((E)-2 hydroxybenzylideneamino)cyclohexane-1,2,3-triol) to cultures of the mutant displayed a similar antibacterial activity with neomycin produced by wild strain.
- 650 _2
- $a antibakteriální látky $x biosyntéza $x chemie $7 D000900
- 650 _2
- $a bakteriální proteiny $x genetika $x metabolismus $7 D001426
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a neomycin $x analogy a deriváty $x biosyntéza $7 D009355
- 650 _2
- $a Streptomyces $x enzymologie $x genetika $x metabolismus $7 D013302
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zhang, Xingang $u -
- 700 1_
- $a Wu, Lang $u -
- 700 1_
- $a Xie, Jin $u -
- 700 1_
- $a Tao, Ke $u -
- 700 1_
- $a Hou, Taiping $u -
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 56, č. 6 (2011), s. 555-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22083789 $y Pubmed
- 910 __
- $a ABA008 $b $c $y a
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20121102114258 $b ABA008
- 999 __
- $a ok $b bmc $g 961615 $s 792690
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 56 $c 6 $d 555-61 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20121023-FolMibiolPha11Zahr